Loading…

Cognitive Decline in Severe Intractable Epilepsy

Purpose: To explore the relation between seizure‐related variables and cognitive change in patients with severe intractable epilepsy. Methods: A retrospective analysis of data from 136 patients who had undergone a cognitive assessment on two occasions at an interval of ≥10 years. Cognitive measures...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsia (Copenhagen) 2005-11, Vol.46 (11), p.1780-1787
Main Authors: Thompson, Pamela J., Duncan, John S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583
cites cdi_FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583
container_end_page 1787
container_issue 11
container_start_page 1780
container_title Epilepsia (Copenhagen)
container_volume 46
creator Thompson, Pamela J.
Duncan, John S.
description Purpose: To explore the relation between seizure‐related variables and cognitive change in patients with severe intractable epilepsy. Methods: A retrospective analysis of data from 136 patients who had undergone a cognitive assessment on two occasions at an interval of ≥10 years. Cognitive measures included tests of memory and executive skills in addition to intelligence quotients (IQ). Details were available regarding seizure type and frequency in the intertest interval. Results: Cognitive decline was severe and occurred across a wide range of cognitive functions. The frequency of generalised tonic–clonic seizures was the strongest predictor of decline. Complex partial seizure frequency was associated with a decline in memory and executive skills but not in IQ. Seizure‐related head injuries and advancing age carried a poor cognitive prognosis, whereas periods of remission were associated with a better cognitive outcome. Early age at onset was not implicated, and duration of epilepsy was a much less potent predictor of cognitive decline than has been reported in cross‐sectional studies. No evidence indicated that a higher level of cognitive function protected against cognitive decline. Conclusions: Our findings, together with those from animal studies and surgically treated patients, suggest that seizures can have a direct adverse effect on cognition and that good seizure control even after years of intractability can have a beneficial impact on cognitive prognosis. This study was based on individuals who merited two cognitive assessments ≥10 years apart and hence is biased in favor of those with the most severe forms of refractory epilepsy and those with decline.
doi_str_mv 10.1111/j.1528-1167.2005.00279.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68821192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68821192</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583</originalsourceid><addsrcrecordid>eNqNkEtPwkAQgDdGI4j-BdOL3lpnd7uPJl4MopKQaKKeN9NlakpKwS4g_HuLEDnqXGaS-eaRj7GIQ8LbuJkkXAkbc65NIgBUAiBMlqyPWPe3ccy6AFzGmbLQYWchTADAaCNPWYdrCcIq22XQn33U5aJcUXRPvipriso6eqUVNRQN60WDfoF5RdFgXlY0D5tzdlJgFehin3vs_WHw1n-KR8-Pw_7dKPbKiCzOSemMo0YhjMY85ZIgG-eY-iK1WpJJyaAWviis0p7GMscsR4kWxxyksrLHrnd7583sc0lh4aZl8FRVWNNsGZy2VnCeiT9BAZkwXKsWtDvQN7MQGircvCmn2GwcB7fV6iZua89t7bmtVvej1a3b0cv9jWU-pfFhcO-xBa72AAaPVdFg7ctw4IyUVqe65W533Fdrc_PvB9zgZdgW8huCOpGm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20927165</pqid></control><display><type>article</type><title>Cognitive Decline in Severe Intractable Epilepsy</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Thompson, Pamela J. ; Duncan, John S.</creator><creatorcontrib>Thompson, Pamela J. ; Duncan, John S.</creatorcontrib><description>Purpose: To explore the relation between seizure‐related variables and cognitive change in patients with severe intractable epilepsy. Methods: A retrospective analysis of data from 136 patients who had undergone a cognitive assessment on two occasions at an interval of ≥10 years. Cognitive measures included tests of memory and executive skills in addition to intelligence quotients (IQ). Details were available regarding seizure type and frequency in the intertest interval. Results: Cognitive decline was severe and occurred across a wide range of cognitive functions. The frequency of generalised tonic–clonic seizures was the strongest predictor of decline. Complex partial seizure frequency was associated with a decline in memory and executive skills but not in IQ. Seizure‐related head injuries and advancing age carried a poor cognitive prognosis, whereas periods of remission were associated with a better cognitive outcome. Early age at onset was not implicated, and duration of epilepsy was a much less potent predictor of cognitive decline than has been reported in cross‐sectional studies. No evidence indicated that a higher level of cognitive function protected against cognitive decline. Conclusions: Our findings, together with those from animal studies and surgically treated patients, suggest that seizures can have a direct adverse effect on cognition and that good seizure control even after years of intractability can have a beneficial impact on cognitive prognosis. This study was based on individuals who merited two cognitive assessments ≥10 years apart and hence is biased in favor of those with the most severe forms of refractory epilepsy and those with decline.</description><identifier>ISSN: 0013-9580</identifier><identifier>EISSN: 1528-1167</identifier><identifier>DOI: 10.1111/j.1528-1167.2005.00279.x</identifier><identifier>PMID: 16302858</identifier><identifier>CODEN: EPILAK</identifier><language>eng</language><publisher>350 Main Street , Malden , MA 02148 , USA and 9600 Garsington Road , Oxford , OX4 2XG , England: Blackwell Science Inc</publisher><subject>Adult ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Cognition Disorders - diagnosis ; Cognition Disorders - epidemiology ; Cognitive decline ; Comorbidity ; Epilepsy ; Epilepsy - diagnosis ; Epilepsy - epidemiology ; Epilepsy - therapy ; Epilepsy, Tonic-Clonic - diagnosis ; Epilepsy, Tonic-Clonic - epidemiology ; Epilepsy, Tonic-Clonic - therapy ; Female ; Follow-Up Studies ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Intelligence ; Longitudinal Studies ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Nervous system (semeiology, syndromes) ; Neurology ; Neuropharmacology ; Neuropsychological Tests - statistics &amp; numerical data ; Neurosurgery ; Pharmacology. Drug treatments ; Prognosis ; Regression Analysis ; Retrospective Studies ; Seizures ; Severity of Illness Index ; Skull, brain, vascular surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Syncope - diagnosis ; Syncope - epidemiology ; Treatment Outcome ; United Kingdom - epidemiology</subject><ispartof>Epilepsia (Copenhagen), 2005-11, Vol.46 (11), p.1780-1787</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583</citedby><cites>FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17338646$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16302858$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thompson, Pamela J.</creatorcontrib><creatorcontrib>Duncan, John S.</creatorcontrib><title>Cognitive Decline in Severe Intractable Epilepsy</title><title>Epilepsia (Copenhagen)</title><addtitle>Epilepsia</addtitle><description>Purpose: To explore the relation between seizure‐related variables and cognitive change in patients with severe intractable epilepsy. Methods: A retrospective analysis of data from 136 patients who had undergone a cognitive assessment on two occasions at an interval of ≥10 years. Cognitive measures included tests of memory and executive skills in addition to intelligence quotients (IQ). Details were available regarding seizure type and frequency in the intertest interval. Results: Cognitive decline was severe and occurred across a wide range of cognitive functions. The frequency of generalised tonic–clonic seizures was the strongest predictor of decline. Complex partial seizure frequency was associated with a decline in memory and executive skills but not in IQ. Seizure‐related head injuries and advancing age carried a poor cognitive prognosis, whereas periods of remission were associated with a better cognitive outcome. Early age at onset was not implicated, and duration of epilepsy was a much less potent predictor of cognitive decline than has been reported in cross‐sectional studies. No evidence indicated that a higher level of cognitive function protected against cognitive decline. Conclusions: Our findings, together with those from animal studies and surgically treated patients, suggest that seizures can have a direct adverse effect on cognition and that good seizure control even after years of intractability can have a beneficial impact on cognitive prognosis. This study was based on individuals who merited two cognitive assessments ≥10 years apart and hence is biased in favor of those with the most severe forms of refractory epilepsy and those with decline.</description><subject>Adult</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - epidemiology</subject><subject>Cognitive decline</subject><subject>Comorbidity</subject><subject>Epilepsy</subject><subject>Epilepsy - diagnosis</subject><subject>Epilepsy - epidemiology</subject><subject>Epilepsy - therapy</subject><subject>Epilepsy, Tonic-Clonic - diagnosis</subject><subject>Epilepsy, Tonic-Clonic - epidemiology</subject><subject>Epilepsy, Tonic-Clonic - therapy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Intelligence</subject><subject>Longitudinal Studies</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Neuropsychological Tests - statistics &amp; numerical data</subject><subject>Neurosurgery</subject><subject>Pharmacology. Drug treatments</subject><subject>Prognosis</subject><subject>Regression Analysis</subject><subject>Retrospective Studies</subject><subject>Seizures</subject><subject>Severity of Illness Index</subject><subject>Skull, brain, vascular surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Syncope - diagnosis</subject><subject>Syncope - epidemiology</subject><subject>Treatment Outcome</subject><subject>United Kingdom - epidemiology</subject><issn>0013-9580</issn><issn>1528-1167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqNkEtPwkAQgDdGI4j-BdOL3lpnd7uPJl4MopKQaKKeN9NlakpKwS4g_HuLEDnqXGaS-eaRj7GIQ8LbuJkkXAkbc65NIgBUAiBMlqyPWPe3ccy6AFzGmbLQYWchTADAaCNPWYdrCcIq22XQn33U5aJcUXRPvipriso6eqUVNRQN60WDfoF5RdFgXlY0D5tzdlJgFehin3vs_WHw1n-KR8-Pw_7dKPbKiCzOSemMo0YhjMY85ZIgG-eY-iK1WpJJyaAWviis0p7GMscsR4kWxxyksrLHrnd7583sc0lh4aZl8FRVWNNsGZy2VnCeiT9BAZkwXKsWtDvQN7MQGircvCmn2GwcB7fV6iZua89t7bmtVvej1a3b0cv9jWU-pfFhcO-xBa72AAaPVdFg7ctw4IyUVqe65W533Fdrc_PvB9zgZdgW8huCOpGm</recordid><startdate>200511</startdate><enddate>200511</enddate><creator>Thompson, Pamela J.</creator><creator>Duncan, John S.</creator><general>Blackwell Science Inc</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200511</creationdate><title>Cognitive Decline in Severe Intractable Epilepsy</title><author>Thompson, Pamela J. ; Duncan, John S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - epidemiology</topic><topic>Cognitive decline</topic><topic>Comorbidity</topic><topic>Epilepsy</topic><topic>Epilepsy - diagnosis</topic><topic>Epilepsy - epidemiology</topic><topic>Epilepsy - therapy</topic><topic>Epilepsy, Tonic-Clonic - diagnosis</topic><topic>Epilepsy, Tonic-Clonic - epidemiology</topic><topic>Epilepsy, Tonic-Clonic - therapy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Intelligence</topic><topic>Longitudinal Studies</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Neuropsychological Tests - statistics &amp; numerical data</topic><topic>Neurosurgery</topic><topic>Pharmacology. Drug treatments</topic><topic>Prognosis</topic><topic>Regression Analysis</topic><topic>Retrospective Studies</topic><topic>Seizures</topic><topic>Severity of Illness Index</topic><topic>Skull, brain, vascular surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Syncope - diagnosis</topic><topic>Syncope - epidemiology</topic><topic>Treatment Outcome</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thompson, Pamela J.</creatorcontrib><creatorcontrib>Duncan, John S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Epilepsia (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thompson, Pamela J.</au><au>Duncan, John S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive Decline in Severe Intractable Epilepsy</atitle><jtitle>Epilepsia (Copenhagen)</jtitle><addtitle>Epilepsia</addtitle><date>2005-11</date><risdate>2005</risdate><volume>46</volume><issue>11</issue><spage>1780</spage><epage>1787</epage><pages>1780-1787</pages><issn>0013-9580</issn><eissn>1528-1167</eissn><coden>EPILAK</coden><abstract>Purpose: To explore the relation between seizure‐related variables and cognitive change in patients with severe intractable epilepsy. Methods: A retrospective analysis of data from 136 patients who had undergone a cognitive assessment on two occasions at an interval of ≥10 years. Cognitive measures included tests of memory and executive skills in addition to intelligence quotients (IQ). Details were available regarding seizure type and frequency in the intertest interval. Results: Cognitive decline was severe and occurred across a wide range of cognitive functions. The frequency of generalised tonic–clonic seizures was the strongest predictor of decline. Complex partial seizure frequency was associated with a decline in memory and executive skills but not in IQ. Seizure‐related head injuries and advancing age carried a poor cognitive prognosis, whereas periods of remission were associated with a better cognitive outcome. Early age at onset was not implicated, and duration of epilepsy was a much less potent predictor of cognitive decline than has been reported in cross‐sectional studies. No evidence indicated that a higher level of cognitive function protected against cognitive decline. Conclusions: Our findings, together with those from animal studies and surgically treated patients, suggest that seizures can have a direct adverse effect on cognition and that good seizure control even after years of intractability can have a beneficial impact on cognitive prognosis. This study was based on individuals who merited two cognitive assessments ≥10 years apart and hence is biased in favor of those with the most severe forms of refractory epilepsy and those with decline.</abstract><cop>350 Main Street , Malden , MA 02148 , USA and 9600 Garsington Road , Oxford , OX4 2XG , England</cop><pub>Blackwell Science Inc</pub><pmid>16302858</pmid><doi>10.1111/j.1528-1167.2005.00279.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0013-9580
ispartof Epilepsia (Copenhagen), 2005-11, Vol.46 (11), p.1780-1787
issn 0013-9580
1528-1167
language eng
recordid cdi_proquest_miscellaneous_68821192
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects Adult
Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Cognition Disorders - diagnosis
Cognition Disorders - epidemiology
Cognitive decline
Comorbidity
Epilepsy
Epilepsy - diagnosis
Epilepsy - epidemiology
Epilepsy - therapy
Epilepsy, Tonic-Clonic - diagnosis
Epilepsy, Tonic-Clonic - epidemiology
Epilepsy, Tonic-Clonic - therapy
Female
Follow-Up Studies
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Intelligence
Longitudinal Studies
Magnetic Resonance Imaging
Male
Medical sciences
Nervous system (semeiology, syndromes)
Neurology
Neuropharmacology
Neuropsychological Tests - statistics & numerical data
Neurosurgery
Pharmacology. Drug treatments
Prognosis
Regression Analysis
Retrospective Studies
Seizures
Severity of Illness Index
Skull, brain, vascular surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Syncope - diagnosis
Syncope - epidemiology
Treatment Outcome
United Kingdom - epidemiology
title Cognitive Decline in Severe Intractable Epilepsy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A42%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20Decline%20in%20Severe%20Intractable%20Epilepsy&rft.jtitle=Epilepsia%20(Copenhagen)&rft.au=Thompson,%20Pamela%20J.&rft.date=2005-11&rft.volume=46&rft.issue=11&rft.spage=1780&rft.epage=1787&rft.pages=1780-1787&rft.issn=0013-9580&rft.eissn=1528-1167&rft.coden=EPILAK&rft_id=info:doi/10.1111/j.1528-1167.2005.00279.x&rft_dat=%3Cproquest_cross%3E68821192%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5729-be5691a6a2276ab413e09dba4cf4863e74e7a62cff856ced3ba9ba3a8ad103583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20927165&rft_id=info:pmid/16302858&rfr_iscdi=true